Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Merck
Harvard Business School
AstraZeneca
Dow

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

Litigation Details for Forest Laboratories LLC v. Amneal Pharmaceuticals LLC (D. Del. 2015)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Forest Laboratories LLC v. Amneal Pharmaceuticals LLC (D. Del. 2015)

Docket   Start Trial Date Filed 2015-08-27
Court District Court, D. Delaware Date Terminated 2016-09-02
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties ADAMAS PHARMACEUTICALS INC.; ALLERGAN USA, INC.; AMNEAL PHARMACEUTICALS LLC; AMNEAL PHARMACEUTICALS OF NEW YORK LLC; FOREST LABORATORIES HOLDINGS LTD.; FOREST LABORATORIES LLC; PAR PHARMACEUTICAL, INC.
Patents 8,058,291; 8,168,209; 8,173,708; 8,283,379; 8,293,794; 8,329,752; 8,338,485; 8,338,486; 8,362,085; 8,580,858; 8,598,233
Attorneys Alfred Henry Heckel; Anandita Vyakarnam; Andrew J. Allen; Anne Shea Gaza; Constance S. Huttner; Jack B. Blumenfeld; Mary Matterer; Maryellen Noreika; Ricardo Rodriguez; Samantha G. Wilson; Stuart D. Sender
Link to Docket External link to docket
Small Molecule Drugs cited in Forest Laboratories LLC v. Amneal Pharmaceuticals LLC
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Forest Laboratories LLC v. Amneal Pharmaceuticals LLC (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-08-27 1 quot;the '009 patent"); 8,058,291 ("the '291 patent"); 8,168,209, as corrected (&…#39;009 patent, the '291 patent, the '209 patent, the '708 patent, the '379 patent, the …#39;794 patent, the '752 patent, the '485 patent, the '486 patent, the '085 patent, the …;009 patent, the '291 patent, the '209 patent, the '708 patent, the '379 patent, the …;794 patent, the '752 patent, the '485 patent, the '486 patent, the '085 patent, the External link to document
2016-08-31 102 .S. Patent Nos. 8,039,009 ("the '009 Patent"), 8,058,291 ("the '291 Patent"…;009 Patent, the '291 Patent, the '209 Patent, the '708 Patent, the '379 Patent, the …;794 Patent, the '752 Patent, the '485 Patent, the '486 Patent, the '085 Patent, the …;009 Patent, the '291 Patent, the '209 Patent, the '708 Patent, the '379 Patent, the …;794 Patent, the '752 Patent, the '485 Patent, the '486 Patent, the '085 Patent, the External link to document
2015-11-23 23 of, U.S. Patent Nos. 8,168,209, as corrected (“the ‘209 patent”); 8,173,708 (“the ‘708 patent”); 8,283,379…,379 (“the ‘379 patent”); 8,329,752 (“the ‘752 patent”); 8,362,085 (“the ‘085 patent”); 8,598,233 (“the…“the ‘233 patent”) and 8,039,009 (“the ‘009 patent”). These patents are also at issue in Civil Action… Judge Stark’s Revised Procedures for Managing Patent Cases (which is posted at http://www.ded.uscourts.gov…www.ded.uscourts.gov.; see Chambers, Judge Leonard P. Stark, Patent Cases) on , 2015, and External link to document
2015-08-27 5 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,039,009 B2; 8,058,291 B2; 8,168,209… 2 September 2016 1:15-cv-00756 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Baxter
Merck
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.